Prokupets Elena 4
4 · C4 Therapeutics, Inc. · Filed Sep 21, 2021
Insider Transaction Report
Form 4
Prokupets Elena
Director
Transactions
- Sale
Common Stock
2021-09-21$50.14/sh−5,333$267,410→ 526,364 total(indirect: By ERP Business Holdings, LP) - Sale
Common Stock
2021-09-17$50.05/sh−5,688$284,687→ 531,697 total(indirect: By ERP Business Holdings, LP) - Sale
Common Stock
2021-09-21$50.13/sh−4,988$250,051→ 43,036 total(indirect: By Spouse) - Sale
Common Stock
2021-09-17$50.04/sh−5,152$257,808→ 48,024 total(indirect: By Spouse)
Footnotes (5)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021.
- [F4]Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.